The Role of Multimodality Imaging in Left Atrial Appendage Closure (MILAAC)
Atrial Fibrillation
About this trial
This is an interventional diagnostic trial for Atrial Fibrillation focused on measuring atrial fibrillation, ischemic stroke, left atrial appendage closure, bleeding
Eligibility Criteria
Inclusion Criteria:
- Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025
- Age above 18 years
- Informed consent
- Legal capacity
Exclusion Criteria:
- Age under 18 years
- Pregnancy
- Incapacitation
- Absence of consent
- Esophageal stenosis or diverticulum
- Active esophageal bleeding
- CT-contrast agent allergy
- Severe chronic kidney disease (GFR<15 ml/min/1,73 m2)
- Appendage thrombus (mobile/with significant embolic risk)
- Life expectancy shorter than 12 months
- Active infection
- Significant mitral valve stenosis
- Mechanical heart valve
- Open heart surgery is indicated
Sites / Locations
- Hungarian Institute of Cardiology (Gottsegen National Cardiovascular Center)Recruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Multimodal imaging
Standard imaging
Preoperative 2D/3D TOE AND MDCT for appendage characterisation and sizing Operative 2D/3D TOE and fluoroscopy/angiography for guiding and checking the procedural events and success Postoperative 2D/3D TOE and MDCT to assess the complications (peri-device leak, thrombus)
Preoperative MDCT for appendage characterisation and sizing Operative 2D/3D TOE and fluoroscopy/angiography for guiding and checking the procedural events and success Postoperative 2D/3D TOE and MDCT to assess the complications (peri-device leak, thrombus)